CDSCO Panel Gives Conditional nod to Azelnidipine and Olmesartan FDC MD Bureau18 Jan 2021 6:51 PM ISTNew Delhi: Following the submission of bioequivalence (BE) study report by Akum Drugs, the Central Drug Standard Control...
Bharat Biotech Covaxin safe to use, efficacy meets WHO standards: Joint Drugs Controller MD Bureau18 Jan 2021 11:30 AM ISTNew Delhi: Allaying the apprehensions associated with the safety of the vaccine developed by Bharat Biotech, S. Eswara Reddy, Joint Drugs...
AstraZeneca gets CDSCO nod for Dapagliflozin in CKD MD Bureau17 Jan 2021 3:30 PM ISTNew Delhi: The Subject Expert Committee (SEC), operative under the Central Drugs Standard Control Organization (CDSCO), has given its nod to...
Emcure Secures CDSCO Committee nod for manufacturing, marketing of Metoprolol Telmisartan FDC MD Bureau16 Jan 2021 5:01 PM ISTNew Delhi: After reviewing the Bioequivalence (BE) study report of the fixed-dose combination (FDC) of Metoprolol Telmisartan, the Central Drugs...
Former AIIMS director, experts come in defense of Covid-19 vaccines- Covaxin, Covishield, slam skeptics Medical Dialogues Bureau16 Jan 2021 4:45 PM ISTNew Delhi: Slamming the skeptics for doubting the efficacy of two Covid-19 vaccines, Covishield and Covaxin, a group of 49 doctors, scientists, and...
Covid-19: Delhi govt diverts Covaxin to 6 Centre-run hospitals including AIIMS Medical Dialogues Bureau16 Jan 2021 9:30 AM ISTThe move is expected to court controversy since the healthcare workers already have a reservation against Bharat Biotech's Covaxin which received...
NPPA brings Remoglifozin, Metformin combination under price control, pulls up Mankind, Intas Pharma for unapproved launch Farhat Nasim15 Jan 2021 7:06 PM ISTNew Delhi: In its recent most attempt to bring drugs under price control, NPPA has now set the maximum price for the FDC of Remoglifozin Etabonate and...
Cadila Healthcare gets CDSCO panel go-ahead for Phase 3 trial of Novel Corona Virus 2019-nCoV Vaccine MD Bureau7 Jan 2021 5:28 PM ISTNew Delhi: Pharmaceutical major, Cadila Healthcare has got a go-ahead from the Subject Expert Committee (SEC) of the Central Drugs Standard Control...
Wockhardt secures CDSCO panel conditional nod to conduct Phase IV Trial of Levonadifloxacin MD Bureau6 Jan 2021 6:18 PM ISTNew Delhi: Pharmaceutical and biotechnology major Wockhardt Ltd. has recently secured permission from the Subject Expert Committee (SEC) of the...
AIDAN slams approval of Covaxin, expresses alarm over lack of efficacy, trial data Farhat Nasim5 Jan 2021 4:42 PM ISTNew Delhi: Slamming the recent approval of Covid-19 vaccine, Covaxin, developed by Bharat Biotech in association with the Indian Council of...
CDSCO panel directs Themis Medicare to conduct blinded trial of Inosine Pranobex in Moderate Covid-19 patient MD Bureau3 Jan 2021 11:00 AM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drugs Standard Control Organisation (CDSCO) recently recommended Themis...
Setback to Bharat Biotech: CDSCO panel rejects to approve Covaxin, seeks more data MD Bureau2 Jan 2021 12:00 PM ISTNew Delhi: The Subject Expert Committee of the Central Drug Standard Control Organisation on Friday has held that the data provided by Bharat Biotech...
